BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.91B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.41B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.16B |
| 4 |
Apple
AAPL
|
+$704M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$115M |
| 2 |
iShares US Financials ETF
IYF
|
+$109M |
| 3 |
Visa
V
|
+$108M |
| 4 |
Charter Communications
CHTR
|
+$73.8M |
| 5 |
Honeywell
HON
|
+$58.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.66% |
| 2 | Healthcare | 6.66% |
| 3 | Financials | 5.71% |
| 4 | Consumer Discretionary | 5.02% |
| 5 | Communication Services | 4.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Univest Financial
UVSP
$1.18B
| $146K | ﹤0.01% |
8,932
+5,608
| +169% | +$128K |
|
2877
Banc of California
BANC
$3.1B
| $145K | ﹤0.01% |
18,185
+8,108
| +80% | +$119K |
|
2878
Enovis
ENOV
$1.42B
| $145K | ﹤0.01% |
4,269
-2,866
| -40% | -$158K |
|
2879
Wendy's
WEN
$1.65B
| $145K | ﹤0.01% |
9,745
-127,547
| -93% | -$2.51M |
|
2880
Extreme Networks
EXTR
$3.2B
| $145K | ﹤0.01% |
46,905
+20,732
| +79% | +$115K |
|
2881
World Acceptance Corp
WRLD
$884M
| $144K | ﹤0.01% |
2,645
-586
| -18% | -$45.4K |
|
|
TECX
2882
Tectonic Therapeutic
TECX
$720M
| $144K | ﹤0.01% |
772
-5,904
| -88% | -$1.39M |
|
|
WIFI
2883
DELISTED
Boingo Wireless, Inc.
WIFI
| $144K | ﹤0.01% |
13,531
+7,011
| +108% | +$81.3K |
|
2884
Jack in the Box
JACK
$358M
| $143K | ﹤0.01% |
4,087
-14,720
| -78% | -$1M |
|
|
PETQ
2885
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $143K | ﹤0.01% |
6,149
+3,810
| +163% | +$106K |
|
|
AXNX
2886
DELISTED
Axonics, Inc. Common Stock
AXNX
| $142K | ﹤0.01% |
5,606
+3,809
| +212% | +$113K |
|
|
QADA
2887
DELISTED
QAD Inc.
QADA
| $142K | ﹤0.01% |
3,563
+1,302
| +58% | +$61.7K |
|
2888
Scotiabank
BNS
$110B
| $142K | ﹤0.01% |
3,500
| – | – |
|
2889
1st Source
SRCE
$2.13B
| $142K | ﹤0.01% |
4,364
+902
| +26% | +$39K |
|
2890
Kura Oncology
KURA
$882M
| $141K | ﹤0.01% |
14,192
+10,176
| +253% | +$116K |
|
|
TGI
2891
DELISTED
Triumph Group
TGI
| $141K | ﹤0.01% |
20,889
+1,722
| +9% | +$31.5K |
|
2892
Eldorado Gold
EGO
$10.4B
| $141K | ﹤0.01% |
22,886
-15,559
| -40% | -$117K |
|
2893
Voyager Therapeutics
VYGR
$197M
| $141K | ﹤0.01% |
15,432
+12,648
| +454% | +$145K |
|
2894
BioCryst Pharmaceuticals
BCRX
$2.71B
| $141K | ﹤0.01% |
70,517
+53,338
| +310% | +$147K |
|
2895
Tucows
TCX
$140M
| $141K | ﹤0.01% |
2,917
+1,531
| +110% | +$85.7K |
|
2896
Resources Connection
RGP
$144M
| $140K | ﹤0.01% |
12,783
+2,061
| +19% | +$28K |
|
2897
Chunghwa Telecom
CHT
$32.8B
| $140K | ﹤0.01% |
3,923
-747
| -16% | -$26.9K |
|
|
GOOD
2898
Gladstone Commercial Corp
GOOD
$641M
| $140K | ﹤0.01% |
9,717
+2,920
| +43% | +$55.6K |
|
2899
Arcus Biosciences
RCUS
$3.67B
| $139K | ﹤0.01% |
10,027
+2,139
| +27% | +$26.6K |
|
2900
Nabors Industries
NBR
$1.33B
| $139K | ﹤0.01% |
7,131
-3,845
| -35% | -$352K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2020 Portfolio in Review
As of Q1 2020, BNP Paribas Financial Markets held 4,585 positions worth $48.8B, down 11% from $54.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
BNP Paribas Financial Markets deployed $12.8B of net new capital in Q1 2020, opening 132 new positions and adding to 2,502 existing holdings. Its largest new stake was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $115M trimmed.
- BNP Paribas Financial Markets's largest Q1 2020 buy was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $2.91B increase.
- BNP Paribas Financial Markets's biggest Q1 2020 reduction was Pfizer, cutting an estimated $115M.
- BNP Paribas Financial Markets fully exited State Street SPDR S&P Health Care Equipment ETF in Q1 2020, selling an estimated $47.1M.
- BNP Paribas Financial Markets's ten largest holdings make up 21% of its $48.8B portfolio in Q1 2020.
- BNP Paribas Financial Markets opened 132 new positions and closed 257 in Q1 2020.
- BNP Paribas Financial Markets's portfolio value fell 11% quarter-over-quarter to $48.8B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2020, filed 13 May 2020.